Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAt-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists
Brain, 07/01/09
Abler B et al. - The results support the notion of a general medication effect in patients under dopamine receptor agonists in terms of a sensitization towards impulse control disorders.
Related Articles
Dopamine agonist-induced antecollis in Parkinsons disease
Movement Disorders, 11/18/09
Relevance Score: 71%
Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
Cochrane Reviews, 10/09/09
Relevance Score: 70%
Prolactin and Autoimmunity
Clinical Reviews in Allergy and Immunology, 11/18/09
Relevance Score: 64%
The pragmatic use of apomorphine at the end of life
Palliative Medicine, 10/30/09
Relevance Score: 64%
Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole
Current Medical Research and Opinion, 10/26/09
Relevance Score: 64%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid
Multiple Sclerosis, 12/11/09
Behavioral Dimensions and Acetylcholinesterase Inhibitor-related Effect in Alzheimer Disease Over Time: A Latent Trajectory Modeling
Cognitive and Behavioral Neurology, 12/11/09
Depression in Parkinson's Disease
Canadian Journal of Neurological Sciences, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor